Financial results are lacking, but the growth story looks highly intact as Red Cat has shared promising developments. See why I rate RCAT stock a hold.
RBC justified the new price target by pointing to the improved profitability and higher estimates that emerged from the recent guidance. Nonetheless, the firm's analysts remain cautious, suggesting ...
In a turbulent market session, VIRX, the stock of Sunesis Pharmaceuticals (NASDAQ:VIRX), plummeted to a 52-week low, reaching a distressing price level of $0.08. According to InvestingPro data, the ...